-
301
Un-biased housekeeping gene panel selection for high-validity gene expression analysis
Published 2022-07-01Get full text
Article -
302
-
303
-
304
-
305
Chronic periodontitis, dantamoolaroga, indicates chronic systemic inflammation and reduces longevity
Published 2024-11-01“…It is found that oral health reflects systemic health and provides a window into general health. As personalised medicine is being developed to assess the multiple pathophysiological factors underlying systemic chronic inflammation, it is noted that Ayurveda has a comprehensive approach to diagnosis with the 10 fold assessment (Dashavidha Praiksha) and eight fold examinations (Astasthana Pariksha) being considered the original personalised medicine. …”
Get full text
Article -
306
-
307
-
308
Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
Published 2025-01-01“…GBOs currently hold significant promise, with the potential to emerge as the key translational tool to synergise and enhance next-generation omics efforts and guide personalised medicine approaches for brain cancer patients into the future.…”
Get full text
Article -
309
A perspective for sequencing familial hypercholesterolaemia in African Americans
Published 2018“…The purpose of this paper is to provide a perspective, using familial hypercholesterolaemia as an exemplar, that studies evaluating genetic variation focused within minority populations are necessary to identify factors that contribute to disparities in health outcomes and realise the full utility of personalised medicine.…”
Get full text
Get full text
Article -
310
HbA1c for type 2 diabetes diagnosis in Africans and African Americans: Personalized medicine NOW!
Published 2017-09-01“…Andrew Paterson discusses findings from a new study that shows HbA1c screening for diabetes will leave 2% of African Americans undiagnosed and how personalised medicine is needed.…”
Get full text
Article -
311
The Convergence of Nanotechnology, Biotechnology and Cancer Medicine in the Fourth Industrial Revolution
Published 2019-10-01“…Medical technologies of the fourth industrial revolution (Industry 4.0), such as nanotechnology, biotechnology, artificial intelligence (AI), 3D printing and advanced materials are already transforming medical technology and the pharmaceutical industry by offering accurate diagnoses, targeting therapies with fewer side effects, and providing better medical imaging and personalised medicine.…”
Get full text
Article -
312
The Convergence of Nanotechnology, Biotechnology and Cancer Medicine in the Fourth Industrial Revolution
Published 2019-10-01“… Medical technologies of the fourth industrial revolution (Industry 4.0), such as nanotechnology, biotechnology, artificial intelligence (AI), 3D printing and advanced materials are already transforming medical technology and the pharmaceutical industry by offering accurate diagnoses, targeting therapies with fewer side effects, and providing better medical imaging and personalised medicine. …”
Get full text
Article -
313
-
314
-
315
Genomic testing in international guidelines
Published 2013-10-01“…It seems that North America and some European countries have initiated a shift towards a personalised medicine with multigene arrays based on RT-PCR or microarrays.…”
Get full text
Article -
316
Global research in schizophrenia and serotonin: a bibliometric analysis
Published 2024-08-01“…Future schizophrenia and serotonin research is likely to focus on personalised medicine, alternative therapies, novel pathogenesis of schizophrenia, and the use of emerging technologies such as artificial intelligence.…”
Get full text
Article -
317
Artificial Intelligence for Clinical Prediction: Exploring Key Domains and Essential Functions
Published 2024-01-01“…Discussion: The review highlights AI's transformative impact across various clinical prediction domains, including its role in revolutionising diagnostics, improving prognosis accuracy, aiding in personalised medicine, and enhancing patient safety. AI-driven tools contribute significantly to the efficiency and effectiveness of healthcare delivery. …”
Get full text
Article -
318
Ethical issues raised by new genomic technologies: the case study of newborn genome screening
Published 2023-01-01Get full text
Article -
319
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?
Published 2024-10-01“…This review explores the role of IL-6 in RA pathogenesis, its potential as a treatment target and the significance of personalised medicine in RA management. IL-6 has a dual signalling mechanism, classical and trans-signalling, which influences various intracellular pathways. …”
Get full text
Article -
320